yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.
.
.
senator: sir, i have the numbers in front of me. how can you keep this secret from the public?
.
harvard medical school: "cgrp: a new era for migraine treatment."
.
.
.
.
it shows that the longest waits for cancer treatment have soared since 2010.
.
.
.
.